Neuropsychological impairment associated with substance use by physicians.
Addiction
Medication-assisted treatment
Neurocognitive testing
Physician impairment
Substance use disorder
Journal
Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403
Informations de publication
Date de publication:
15 Apr 2020
15 Apr 2020
Historique:
received:
27
08
2019
revised:
05
11
2019
accepted:
29
01
2020
pubmed:
10
2
2020
medline:
15
5
2021
entrez:
10
2
2020
Statut:
ppublish
Résumé
Physicians and other healthcare professionals are at increased risk for the development of substance use disorders when compared to the general population. Substance use is associated with impairment in neuropsychological functioning, which may impact physicians' ability to practice with reasonable skill and safety. This review describes common neurocognitive deficits observed following use of various substance classes, including stimulants, benzodiazepines, cannabis, alcohol, and opioids. It also reviews the neurocognitive impact of pharmaceutical treatments for opioid use disorder. Clinical implications, including evaluation, treatment, and planning for return-to-work, are discussed. The importance of continued testing/monitoring following the acute treatment phase is emphasized. A case example highlights important issues that must be considered when a physician is referred due to suspected impairment.
Identifiants
pubmed: 32036159
pii: S0022-510X(20)30050-2
doi: 10.1016/j.jns.2020.116714
pii:
doi:
Substances chimiques
Central Nervous System Stimulants
0
Benzodiazepines
12794-10-4
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
116714Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest None.